Gilead Invest Advisor

Cantor Fitzgerald Maintains Neutral Rating on Gilead Sciences (GILD) Dec 14, 2024

Gilead Sciences (GILD) Surpasses Q2 Earnings Expectations, Upgrades Financial Outlook Aug 10, 2024